Related references
Note: Only part of the references are listed.Immune checkpoint combinations from mouse to man
Midan Ai et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2015)
Combination of 4-1BB Agonist and PD-1 Antagonist Promotes Antitumor Effector/Memory CD8 T Cells in a Poorly Immunogenic Tumor Model
Shihao Chen et al.
CANCER IMMUNOLOGY RESEARCH (2015)
High expression of OX40 (CD134) and 4-1BB (CD137) molecules on CD4+CD25high cells in children with type 1 diabetes
Agnieszka Szypowska et al.
ADVANCES IN MEDICAL SCIENCES (2014)
CD137 Accurately Identifies and Enriches for Naturally Occurring Tumor-Reactive T Cells in Tumor
Qunrui Ye et al.
CLINICAL CANCER RESEARCH (2014)
Agonistic anti-CD137 antibody treatment leads to antitumor response in mice with liver cancer
Vanessa Gauttier et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
Aptamer-targeted inhibition of mTOR in T cells enhances antitumor immunity
Alexey Berezhnoy et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
被撤回的出版物: Targeting CD137 enhances the efficacy of cetuximab (Retracted article. See vol. 129, pg. 2595, 2019)
Holbrook E. Kohrt et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Galectin-9 controls the therapeutic activity of 4-1BB-targeting antibodies
Shravan Madireddi et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2014)
4-1BB-based Isolation and Expansion of CD8+ T Cells Specific for Self-Tumor and Non-Self-Tumor Antigens for Adoptive T-cell Therapy
Beom K. Choi et al.
JOURNAL OF IMMUNOTHERAPY (2014)
CD137-CD137L Interaction Regulates Atherosclerosis via Cyclophilin A in Apolipoprotein E-Deficient Mice
Yuefeng Li et al.
PLOS ONE (2014)
Focal Radiation Therapy Combined with 4-1BB Activation and CTLA-4 Blockade Yields Long-Term Survival and a Protective Antigen-Specific Memory Response in a Murine Glioma Model
Zineb Belcaid et al.
PLOS ONE (2014)
Targeting 4-1BB Costimulation to the Tumor Stroma with Bispecific Aptamer Conjugates Enhances the Therapeutic Index of Tumor Immunotherapy
Brett Schrand et al.
CANCER IMMUNOLOGY RESEARCH (2014)
Eomesodermin is required for antitumor immunity mediated by 4-1BB-agonist immunotherapy
Chang Song et al.
ONCOIMMUNOLOGY (2014)
TRAF1 phosphorylation on Serine 139 modulates NF-κB activity downstream of 4-1BB in T cells
N. A. Eustache Oussa et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2013)
Combined stimulation of TLR9 and 4.1 BB augments Trp2 peptide vaccine-mediated melanoma rejection by increasing Ag-specific CTL activity and infiltration into tumor sites
Jeong-Im Sin et al.
CANCER LETTERS (2013)
Expression of CD137 on Hodgkin and Reed-Sternberg Cells Inhibits T-cell Activation by Eliminating CD137 Ligand Expression
Weng Tong Ho et al.
CANCER RESEARCH (2013)
Therapeutic PD-1 Pathway Blockade Augments with Other Modalities of Immunotherapy T-Cell Function to Prevent Immune Decline in Ovarian Cancer
Jaikumar Duraiswamy et al.
CANCER RESEARCH (2013)
The effect of CD137-CD137 ligand interaction on phospholipase C signaling pathway in human endothelial cells
Jinchuan Yan et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2013)
Use of Oligonucleotide Aptamer Ligands to Modulate the Function of Immune Receptors
Eli Gilboa et al.
CLINICAL CANCER RESEARCH (2013)
Immunomodulatory Monoclonal Antibodies Combined with Peptide Vaccination Provide Potent Immunotherapy in an Aggressive Murine Neuroblastoma Model
Emily L. Williams et al.
CLINICAL CANCER RESEARCH (2013)
The TNFRs OX40, 4-1BB, and CD40 as targets for cancer immunotherapy
Amy E. Moran et al.
CURRENT OPINION IN IMMUNOLOGY (2013)
4-1BB signal stimulates the activation, expansion, and effector functions of γδ T cells in mice and humans
Seung J. Lee et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2013)
CD134/CD137 dual costimulation-elicited IFN-γ maximizes effector T-cell function but limits Treg expansion
Marie-Clare St Rose et al.
IMMUNOLOGY AND CELL BIOLOGY (2013)
Systemic 4-1BB activation induces a novel T cell phenotype driven by high expression of Eomesodermin
Michael A. Curran et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2013)
T Cell Costimulation with Anti-CD137 Monoclonal Antibodies Is Mediated by K63-Polyubiquitin-Dependent Signals from Endosomes
Ivan Martinez-Forero et al.
JOURNAL OF IMMUNOLOGY (2013)
GITR-Dependent Regulation of 4-1BB Expression: Implications for T Cell Memory and Anti-4-1BB-Induced Pathology
Gloria H. Y. Lin et al.
JOURNAL OF IMMUNOLOGY (2013)
Leukocyte-specific protein 1 links TNF receptor-associated factor 1 to survival signaling downstream of 4-1BB in T cells
Laurent Sabbagh et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2013)
Combined TIM-3 blockade and CD137 activation affords the long-term protection in a murine model of ovarian cancer
Zhiqiang Guo et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2013)
Clinical targeting of the TNF and TNFR superfamilies
Michael Croft et al.
NATURE REVIEWS DRUG DISCOVERY (2013)
Blockade of 4-1BB and 4-1BBL Interaction Reduces Obesity-Induced Skeletal Muscle Inflammation
Ngoc Hoan Le et al.
MEDIATORS OF INFLAMMATION (2013)
CD137 Facilitates the Resolution of Acute DSS-Induced Colonic Inflammation in Mice
Julia M. Martinez Gomez et al.
PLOS ONE (2013)
4-1BB Signaling Activates the T Cell Factor 1 Effector/β-Catenin Pathway with Delayed Kinetics via ERK Signaling and Delayed PI3K/AKT Activation to Promote the Proliferation of CD8+ T Cells
Do Y. Lee et al.
PLOS ONE (2013)
Combinatorial PD-1 Blockade and CD137 Activation Has Therapeutic Efficacy in Murine Cancer Models and Synergizes with Cisplatin
Huafeng Wei et al.
PLOS ONE (2013)
Tumor-Specific Activation of an EGFR-Targeting Probody Enhances Therapeutic Index
Luc R. Desnoyers et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Gene Silencing of 4-1BB by RNA Interference Inhibits Acute Rejection in Rats with Liver Transplantation
Yang Shi et al.
BIOMED RESEARCH INTERNATIONAL (2013)
The TNF receptor-ligands 4-1BB-4-1BBL and GITR-GITRL in NK cell responses
Isabel Barao
FRONTIERS IN IMMUNOLOGY (2013)
Ectopic CD137 expression facilitates the escape of Hodgkin and Reed-Sternberg cells from immunosurveillance
Wan Lu Pang et al.
ONCOIMMUNOLOGY (2013)
Essential complicity of perforin-granzyme and FAS-L mechanisms to achieve tumor rejection following treatment with anti-CD137 mAb
Aizea Morales-Kastresana et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2013)
CD137 Is Expressed in Follicular Dendritic Cell Tumors and in Classical Hodgkin and T-Cell Lymphomas Diagnostic and Therapeutic Implications
Matthew W. Anderson et al.
AMERICAN JOURNAL OF PATHOLOGY (2012)
CD20-specific adoptive immunotherapy for lymphoma using a chimeric antigen receptor with both CD28 and 4-1BB domains: pilot clinical trial results
Brian G. Till et al.
BLOOD (2012)
Oncolytic Virus and Anti-4-1BB Combination Therapy Elicits Strong Antitumor Immunity against Established Cancer
Liza B. John et al.
CANCER RESEARCH (2012)
Adoptive Cell Therapy for Lymphoma with CD4 T Cells Depleted of CD137-Expressing Regulatory T Cells
Matthew J. Goldstein et al.
CANCER RESEARCH (2012)
Combination Immunotherapy with 4-1BBL and CTLA-4 Blockade for the Treatment of Prostate Cancer
Kuang Youlin et al.
CLINICAL & DEVELOPMENTAL IMMUNOLOGY (2012)
CD137 on inflamed lymphatic endothelial cells enhances CCL21-guided migration of dendritic cells
Alvaro Teijeira et al.
FASEB JOURNAL (2012)
Dispensable role for 4-1BB and 4-1BBL in development of vaccinia virus-specific CD8 T cells
Yuan Zhao et al.
IMMUNOLOGY LETTERS (2012)
被撤回的出版物: Stimulation of natural killer cells with a CD137-specific antibody enhances trastuzumab efficacy in xenotransplant models of breast cancer (Retracted article. See vol. 129, pg. 2595, 2019)
Holbrook E. Kohrt et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Cutting Edge: 4-1BB Controls Regulatory Activity in Dendritic Cells through Promoting Optimal Expression of Retinal Dehydrogenase
Seung-Woo Lee et al.
JOURNAL OF IMMUNOLOGY (2012)
A Converse 4-1BB and CD40 Ligand Expression Pattern Delineates Activated Regulatory T Cells (Treg) and Conventional T Cells Enabling Direct Isolation of Alloantigen-Reactive Natural Foxp3+ Treg
Anne Schoenbrunn et al.
JOURNAL OF IMMUNOLOGY (2012)
Immunotherapeutic Synergy Between Anti-CD137 mAb and Intratumoral Administration of a Cytopathic Semliki Forest Virus Encoding IL-12
Jose I. Quetglas et al.
MOLECULAR THERAPY (2012)
4-1BB/4-1BBL Interaction Promotes Obesity-Induced Adipose Inflammation by Triggering Bidirectional Inflammatory Signaling in Adipocytes/Macrophages
Thai Hien Tu et al.
MEDIATORS OF INFLAMMATION (2012)
Safety and Activity of Anti-PD-L1 Antibody in Patients with Advanced Cancer
Julie R. Brahmer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Safety, Activity, and Immune Correlates of Anti-PD-1 Antibody in Cancer
Suzanne L. Topalian et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
SA-4-1BBL Costimulation Inhibits Conversion of Conventional CD4+ T Cells into CD4+FoxP3+ T Regulatory Cells by Production of IFN-γ
Shravan Madireddi et al.
PLOS ONE (2012)
4-1BB Signaling Breaks the Tolerance of Maternal CD8+ T Cells That Are Reactive with Alloantigens
Kwang H. Kim et al.
PLOS ONE (2012)
Prime-Boost Vaccination with SA-4-1BBL Costimulatory Molecule and Survivin Eradicates Lung Carcinoma in CD8+ T and NK Cell Dependent Manner
Abhishek K. Srivastava et al.
PLOS ONE (2012)
Exposure of a Distinct PDCA-1+ (CD317) B Cell Population to Agonistic Anti-4-1BB (CD137) Inhibits T and B Cell Responses Both In Vitro and In Vivo
Dass S. Vinay et al.
PLOS ONE (2012)
Effects of 4-1BB signaling on the biological function of murine dendritic cells
Youlin Kuang et al.
ONCOLOGY LETTERS (2012)
The HIF-1α Hypoxia Response in Tumor-Infiltrating T Lymphocytes Induces Functional CD137 (4-1BB) for Immunotherapy
Asis Palazon et al.
CANCER DISCOVERY (2012)
Targeting 4-1BB (CD137) to enhance CD8 T cell responses with poxviruses and viral antigens
Yuan Zhao et al.
FRONTIERS IN IMMUNOLOGY (2012)
Virotherapy, gene transfer and immunostimulatory monoclonal antibodies
Jose I. Quetglas et al.
ONCOIMMUNOLOGY (2012)
被撤回的出版物: CD137 stimulation enhances the antilymphoma activity of anti-CD20 antibodies (Retracted article. See vol. 134, pg. 658, 2019)
Holbrook E. Kohrt et al.
BLOOD (2011)
Agonist Anti-CD137 mAb Act on Tumor Endothelial Cells to Enhance Recruitment of Activated T Lymphocytes
Asis Palazon et al.
CANCER RESEARCH (2011)
4-1BB signaling beyond T cells
Dass S. Vinay et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2011)
Unified immune modulation by 4-1BB triggering leads to diverse effects on disease progression in vivo
Beom K. Choi et al.
CYTOKINE (2011)
Deficiency for Costimulatory Receptor 4-1BB Protects Against Obesity-Induced Inflammation and Metabolic Disorders
Chu-Sook Kim et al.
DIABETES (2011)
Intratumoral injection of interferon-alpha and systemic delivery of agonist anti-CD137 monoclonal antibodies synergize for immunotherapy
Juan Dubrot et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Triple expression of B7-1, B7-2 and 4-1BBL enhanced antitumor immune response against mouse H22 hepatocellular carcinoma
Guoqiang Li et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2011)
4-1BB Triggering Ameliorates Experimental Autoimmune Encephalomyelitis by Modulating the Balance between Th17 and Regulatory T Cells
Young H. Kim et al.
JOURNAL OF IMMUNOLOGY (2011)
CD134 Plus CD137 Dual Costimulation Induces Eomesodermin in CD4 T Cells To Program Cytotoxic Th1 Differentiation
Harry Z. Qui et al.
JOURNAL OF IMMUNOLOGY (2011)
Costimulation Through the CD137/4-1BB Pathway Protects Human Melanoma Tumor-infiltrating Lymphocytes From Activation-induced Cell Death and Enhances Antitumor Effector Function
Jessica Ann Hernandez-Chacon et al.
JOURNAL OF IMMUNOTHERAPY (2011)
The combination of 4-1BBL and CD40L strongly enhances the capacity of dendritic cells to stimulate HIV-specific T cell responses
Brenda De Keersmaecker et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2011)
Combinatorial Therapy for Liver Metastatic Colon Cancer: Dendritic Cell Vaccine and Low-Dose Agonistic Anti-4-1BB Antibody Co-Stimulatory Signal
Hyunah Lee et al.
JOURNAL OF SURGICAL RESEARCH (2011)
Targeting 4-1BB Costimulation to Disseminated Tumor Lesions With Bi-specific Oligonucleotide Aptamers
Fernando Pastor et al.
MOLECULAR THERAPY (2011)
Combination CTLA-4 Blockade and 4-1BB Activation Enhances Tumor Rejection by Increasing T-Cell Infiltration, Proliferation, and Cytokine Production
Michael A. Curran et al.
PLOS ONE (2011)
Incorporation of 4-1BB ligand into an adenovirus vaccine vector increases the number of functional antigen-specific CD8 T cells and enhances the duration of protection against influenza-induced respiratory disease
Theo J. Moraes et al.
VACCINE (2011)
Human γδ T lymphocytes induce robust NK cell-mediated antitumor cytotoxicity through CD137 engagement
Amudhan Maniar et al.
BLOOD (2010)
Treatment with anti-CD137 mAbs causes intense accumulations of liver T cells without selective antitumor immunotherapeutic effects in this organ
Juan Dubrot et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2010)
4-1BB Ligand as an Effective Multifunctional Immunomodulator and Antigen Delivery Vehicle for the Development of Therapeutic Cancer Vaccines
Rajesh K. Sharma et al.
CANCER RESEARCH (2010)
CD137 (4-1BB) Deficiency Reduces Atherosclerosis in Hyperlipidemic Mice
Hyung Jun Jeon et al.
CIRCULATION (2010)
Biphasic role of 4-1BB in the regulation of mouse cytomegalovirus-specific CD8+ T cells
Ian R. Humphreys et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2010)
CD137 Promotes Proliferation and Survival of Human B Cells
Xiaoyu Zhang et al.
JOURNAL OF IMMUNOLOGY (2010)
CD137-Mediated Pathogenesis from Chronic Hepatitis to Hepatocellular Carcinoma in Hepatitis B Virus-Transgenic Mice
Jun Wang et al.
JOURNAL OF IMMUNOLOGY (2010)
Therapeutic and Tumor-specific Immunity Induced by Combination of Dendritic Cells and Oncolytic Adenovirus Expressing IL-12 and 4-1BBL
Jing-Hua Huang et al.
MOLECULAR THERAPY (2010)
Regulation of Granulocyte and Macrophage Populations of Murine Bone Marrow Cells by G-CSF and CD137 Protein
Dongsheng Jiang et al.
PLOS ONE (2010)
Radiotherapy Enhances Antitumor Effect of Anti-CD137 Therapy in a Mouse Glioma Model
Elizabeth W. Newcomb et al.
RADIATION RESEARCH (2010)
Clinical Experiences With Anti-CD137 and Anti-PD1 Therapeutic Antibodies
Paolo A. Ascierto et al.
SEMINARS IN ONCOLOGY (2010)
Ex vivo expansion of natural killer cells with high cytotoxicity by K562 cells modified to co-express major histocompatibility complex class I chain-related protein A, 4-1BB ligand, and interleukin-15
W. Gong et al.
TISSUE ANTIGENS (2010)
SA-4-1BBL as the immunomodulatory component of a HPV-16 E7 protein based vaccine shows robust therapeutic efficacy in a mouse cervical cancer model
Rajesh K. Sharma et al.
VACCINE (2010)
Therapeutic effect of CD137 immunomodulation in lymphoma and its enhancement by Treg depletion
Roch Houot et al.
BLOOD (2009)
Anti-4-1BB scFv immunogene therapy and low dose cyclophosphamide exhibit a synergistic antitumor effect in established murine lung tumors
Fang Liu et al.
CANCER BIOLOGY & THERAPY (2009)
Costimulation as a Platform for the Development of Vaccines: A Peptide-Based Vaccine Containing a Novel Form of 4-1BB Ligand Eradicates Established Tumors
Rajesh K. Sharma et al.
CANCER RESEARCH (2009)
Host Lymphodepletion Enhances the Therapeutic Activity of an Oncolytic Vaccinia Virus Expressing 4-1BB Ligand
Hong Sung Kim et al.
CANCER RESEARCH (2009)
In vivo depletion of DC impairs the anti-tumor effect of agonistic anti-CD137 mAb
Oihana Murillo et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2009)
Expression of 4-1BB and 4-1BBL in thymocytes during thymus regeneration
Young-Mi Kim et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2009)
Stimulation of the Molecule 4-1BB Enhances Host Defense against Listeria monocytogenes Infection in Mice by Inducing Rapid Infiltration and Activation of Neutrophils and Monocytes
Sang-Chul Lee et al.
INFECTION AND IMMUNITY (2009)
Endogenous 4-1BB Ligand Plays a Critical Role in Protection from Influenza-Induced Disease
Gloria H. Y. Lin et al.
JOURNAL OF IMMUNOLOGY (2009)
Hypercostimulation through 4-1BB Distorts Homeostasis of Immune Cells
Seung-Woo Lee et al.
JOURNAL OF IMMUNOLOGY (2009)
4-1BB Functions As a Survival Factor in Dendritic Cells
Beom K. Choi et al.
JOURNAL OF IMMUNOLOGY (2009)
IFN-γ-indoleamine-2,3 dioxygenase acts as a major suppressive factor in 4-1BB-mediated immune suppression in vivo
Young H. Kim et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2009)
Mechanisms involved in synergistic anticancer effects of anti-4-1BB and cyclophosphamide therapy
Young H. Kim et al.
MOLECULAR CANCER THERAPEUTICS (2009)
A novel form of 4-1BBL has better immunomodulatory activity than an agonistic anti-4-1BB Ab without Ab-associated severe toxicity
Rich-Henry Schabowsky et al.
VACCINE (2009)
Fc-dependent expression of CD137 on human NK cells: insights into agonistic effects of anti-CD137 monoclonal antibodies
Wei Lin et al.
BLOOD (2008)
Combination therapy with cisplatin and anti-4-1BB: Synergistic anticancer effects and amelioration of cisplatin-induced nephrotoxicity
Young H. Kim et al.
CANCER RESEARCH (2008)
4-1BB (CD137) Ligand Enhanced Anti-Tumor Immune Response against Mouse Forestomach Carcinoma In Vivo
Qiaoxia Li et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2008)
Analysis of CD137 and CD137L expression in human primary tumor tissues
Qun Wang et al.
CROATIAN MEDICAL JOURNAL (2008)
Immune regulation and control of regulatory T cells by OX40 and 4-1BB
Takanori So et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2008)
The 4-1BB ligand and 4-1BB expressed on osteoclast precursors enhance RANKL-induced osteoclastogenesis via bi-directional signaling
Jihyun Yang et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2008)
Eradication of established renal cell carcinoma by a combination of 5-fluorouracil and anti-4-1BB monoclonal antibody in mice
Seong-A Ju et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Multivalent 4-1BB binding aptamers costimulate CD8(+) T cells and inhibit tumor growth in mice
James O. McNamara et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Phase I/II Study of Ipilimumab for Patients With Metastatic Melanoma
Jeffrey S. Weber et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
ERK-dependent Bim modulation downstream of the 4-1BB-TRAF1 signaling axis is a critical mediator of CD8 T cell survival in vivo
Laurent Sabbagh et al.
JOURNAL OF IMMUNOLOGY (2008)
4-1BB engagement costimulates NKT cell activation and exacerbates NKT cell ligand-induced airway hyperresponsiveness and inflammation
Dong-Hyeon Kim et al.
JOURNAL OF IMMUNOLOGY (2008)
Self-Antigen Prevents CD8 T Cell Effector Differentiation by CD134 and CD137 Dual Costimulation
Suman Bandyopadhyay et al.
JOURNAL OF IMMUNOLOGY (2008)
Identification of regulatory functions for 4-1BB and 4-1BBL in myelopoiesis and the development of dendritic cells
Seung-Woo Lee et al.
NATURE IMMUNOLOGY (2008)
Overcoming Immunologic Tolerance to Melanoma: Targeting CTLA-4 with Ipilimumab (MDX-010)
Jeffrey Weber
ONCOLOGIST (2008)
The administration of IL-12/GM-CSF and Ig-4-1BB ligand markedly decreases murine floor of mouth squamous cell cancer
Nithin D. Adappa et al.
OTOLARYNGOLOGY-HEAD AND NECK SURGERY (2008)
Ex vivo expansion of CD4+CD25+FoxP3+ T regulatory cells based on synergy between IL-2 and 4-1BB signaling
Kutlu G. Elpek et al.
JOURNAL OF IMMUNOLOGY (2007)
Role of endogenous 4-1BB in the development of systemic lupus erythematosus
Dass S. Vinay et al.
IMMUNOLOGY (2007)
Immune suppression or enhanceme by CD137 T cell costimulation during acute viral infection is time dependent
Benyue Zhang et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Absence of 4-1BB gene function exacerbates lacrimal gland inflammation in autoimmune-prone MRL-Faslpr mice
Dass S. Vinay et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2007)
Established B16 tumors are rejected following treatment with GM-CSF-secreting tumor cell immunotherapy in combination with anti-4-1BB mAb
Betty Li et al.
CLINICAL IMMUNOLOGY (2007)
Mechanisms involved in synergistic anticancer immunity of Anti-4-1BB and Anti-CD4 therapy
Beom K. Choi et al.
CANCER RESEARCH (2007)
Review: Anti-CTLA-4 antibody ipilimumab: Case studies of clinical response and immune-related adverse events
Jeffrey Weber
ONCOLOGIST (2007)
Blockade of the 4-1BB (CD137)/4-1BBL and/or CD28/CD80/CD86 costimulatory pathways promotes corneal allograft survival in mice
Tatsuhiko Asai et al.
IMMUNOLOGY (2007)
4-1 BB triggers IL-13 production from T cells to limit the polarized, Th1-mediated inflammation
Su M. Shin et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2007)
Cytokine-mediated disruption of lymphocyte trafficking, hemopoiesis, and induction of lymphopenia, anemia, and thrombocytopenia in anti-CD137-treated mice
Liguo Niu et al.
JOURNAL OF IMMUNOLOGY (2007)
Soluble PD-1 facilitates 4-1BBL-triggered antitumor immunity against murine H22 hepatocarcinoma in vivo
Han Xiao et al.
CLINICAL CANCER RESEARCH (2007)
Tumor cells expressing anti-CD137 scFv induce a tumor-destructive environment
Yi Yang et al.
CANCER RESEARCH (2007)
CD137 is expressed on blood vessel walls at sites of inflammation and enhances monocyte migratory activity
Daniela Drenkard et al.
FASEB JOURNAL (2007)
Modulating protective and pathogenic CD4+ subsets via CD137 in type 1 diabetes
Junichiro Irie et al.
DIABETES (2007)
Enhanced osteoclastogenesis in 4-1BB-deficient mice caused by reduced interleukin-10
Hyun-Hee Shin et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2006)
Enhanced antitumor effect against human telomerase reverse transcriptase (hTERT) by vaccination with chemotactic-hTERT gene-modified tumor cell and the combination with anti-4-1BB monoclonal antibodies
Xiaoyan Lin et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Functional dichotomy between OX40 and 4-1BB in modulating effector CD8 T cell responses
Seung-Woo Lee et al.
JOURNAL OF IMMUNOLOGY (2006)
Inhibition of Th2-mediated allergic airway inflammatory disease by CD137 costimulation
Yonglian Sun et al.
JOURNAL OF IMMUNOLOGY (2006)
Combination therapy with anti-CTL antigen-4 and anti-4-1BB antibodies enhances cancer immunity and reduces autoimmunity
Ergun Kocak et al.
CANCER RESEARCH (2006)
4-IBB ligand enhances tumor-specific immunity of poxvirus vaccines
Chie Kudo-Saito et al.
VACCINE (2006)
4-1BB-mediated amelioration of experimental autoimmune uveoretinitis is caused by indoleamine 2,3-dioxygenase-dependent mechanisms
Beorn K. Choi et al.
CYTOKINE (2006)
Antitumor efficacy of CD137 ligation is maximized by the use of a CD137 single-chain Fv-expressing whole-cell tumor vaccine compared with CD137-specific monoclonal antibody infusion
HT Zhang et al.
MOLECULAR CANCER THERAPEUTICS (2006)
Costimulation of mast cells by 4-1BB, a member of the tumor necrosis factor receptor superfamily, with the high-affinity IgE receptor
H Nishimoto et al.
BLOOD (2005)
Cooperation between 4-1BB and ICOS in the immune response to influenza virus revealed by studies of CD28/ICOS-deficient mice
M Vidric et al.
JOURNAL OF IMMUNOLOGY (2005)
Administration of agonistic anti-4-1BB monoclonal antibody leads to the amelioration of inflammatory bowel disease
J Lee et al.
IMMUNOLOGY LETTERS (2005)
Vaccination with dendritic cells pulsed with apoptotic tumors in combination with Anti-OX40 and Anti-4-1BB monoclonal antibodies induces T cell-mediated protective immunity in Her-2/neu transgenic mice
C Cuadros et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
The systemic administration of Ig-4-1BB ligand in combination with IL-12 gene transfer eradicates hepatic colon carcinoma
DP Xu et al.
GENE THERAPY (2005)
Genetic and functional association of the immune signaling molecule 4-1BB (CD137/TNFRSF9) with type 1 diabetes
JL Cannons et al.
JOURNAL OF AUTOIMMUNITY (2005)
4-1BB (CD137) is required for rapid clearance of Listeria monocytogenes infection
SC Lee et al.
INFECTION AND IMMUNITY (2005)
Immunity to melanoma mediated by 4-1BB is associated with enhanced activity of tumour-infiltrating lymphocytes
SA Ju et al.
IMMUNOLOGY AND CELL BIOLOGY (2005)
Enhanced CD4 T cell responsiveness in the absence of 4-1BB
SW Lee et al.
JOURNAL OF IMMUNOLOGY (2005)
Enhancement of CD4 and CD8 immunity by anti-CD137 (4-1BB) monoclonal antibodies during hepatitis C vaccination with recombinant adenovirus
L Arribillaga et al.
VACCINE (2005)
Cross-linking of 4-1BB activates TCR-signaling pathways in CD8+ T lymphocytes
KO Nam et al.
JOURNAL OF IMMUNOLOGY (2005)
4-1BB-dependent inhibition of immunosuppression by activated CD4+CD25+ T cells
BK Choi et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2004)
NK and CD8+ T cell-mediated eradication of poorly immunogenic B16-F10 melanoma by the combined action of IL-12 gene therapy and 4-1BB costimulation
DP Xu et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
Regulation of dendritic cell function by NK cells: Mechanisms underlying the synergism in the combination therapy of IL-12 and 4-1BB activation
PY Pan et al.
JOURNAL OF IMMUNOLOGY (2004)
Chimeric receptors with 4-1BB signaling capacity provoke potent cytotoxicity against acute lymphoblastic leukemia
C Imai et al.
LEUKEMIA (2004)
Expression and function of 4-1BB during CD4 versus CD8 T cell responses in vivo
W Dawicki et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2004)
4-1BB and OX40 dual costimulation synergistically stimulate primary specific CD8 T cells for robust effector function
SJ Lee et al.
JOURNAL OF IMMUNOLOGY (2004)
4-1BB and OX40 stimulation enhance CD8 and CD4 T-cell responses to a DNA prime, poxvirus boost vaccine
MW Munks et al.
IMMUNOLOGY (2004)
4-1BB and OX40 act independently to facilitate robust CD8 and CD4 recall responses
W Dawicki et al.
JOURNAL OF IMMUNOLOGY (2004)
4-1BB-mediated immunotherapy of rheumatoid (vol 10, pg 1088, 2004)
SK Seo et al.
NATURE MEDICINE (2004)
Improving efficacy of interleukin-12-transfected dendritic cells injected into murine colon cancer with anti-CD137 monoclonal antibodies and alloantigens
I Tirapu et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
Constitutive expression of 4-1BB on T cells enhances CD4+ T cell responses
J Kim et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2003)
Expression of CD137 and its ligand in human neurons, astrocytes, and microglia: Modulation by FGF-2
C Reali et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2003)
Tumor expression of 4-1BB ligand sustains tumor lytic T cells
H Zhang et al.
CANCER BIOLOGY & THERAPY (2003)
Blocking 4-1BB/4-1BB ligand interactions prevents herpetic stromal keratitis
SK Seo et al.
JOURNAL OF IMMUNOLOGY (2003)
4-1BB cross-linking enhances the survival and cell cycle progression of CD4 T lymphocytes
HW Lee et al.
CELLULAR IMMUNOLOGY (2003)
Role of 4-1BB in allograft rejection mediated by CD8+ T cells
J Wang et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2003)
CD137 costimulatory T cell receptor engagement reverses acute disease in lupus-prone NZB x NZW F1 mice
J Foell et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)
NF-κB and AP-1 regulate activation-dependent CD137 (4-1BB) expression in T cells
JO Kim et al.
FEBS LETTERS (2003)
4-1BB (CD137) differentially regulates murine in vivo protein- and polysaccharide-specific immunoglobulin isotype responses to Streptococcus pneumoniae
ZQ Wu et al.
INFECTION AND IMMUNITY (2003)
Anti-4-1BB-based immunotherapy for autoimmune diabetes: lessons from a transgenic non-obese diabetic (NOD) model
HK Sytwu et al.
JOURNAL OF AUTOIMMUNITY (2003)
Induction of 4-1BB (CD137) expression by DNA damaging agents in human T lymphocytes
KM Kim et al.
IMMUNOLOGY (2002)
4-1BB promotes the survival of CD8+ T lymphocytes by increasing expression of Bcl-xL and Bfl-1
HW Lee et al.
JOURNAL OF IMMUNOLOGY (2002)
T cell activation with systemic agonistic antibody versus local 4-1BB ligand gene delivery combined with interleukin-12 eradicate liver metastases of breast cancer
O Martinet et al.
GENE THERAPY (2002)
Immune responses in 4-1BB (CD137)-deficient mice
BS Kwon et al.
JOURNAL OF IMMUNOLOGY (2002)
Temporal segregation of 4-1BB versus CD28-mediated costimulation: 4-1BB ligand influences T cell numbers late in the primary response and regulates the size of the T cell memory response following influenza infection
EM Bertram et al.
JOURNAL OF IMMUNOLOGY (2002)
Administration of agonistic anti-4-1BB monoclonal antibody leads to the amelioration of experimental autoimmune encephalomyelitis
YL Sun et al.
JOURNAL OF IMMUNOLOGY (2002)
Ex vivo expansion of polyclonal and antigen-specific cytotoxic T lymphocytes by artificial APCs expressing ligands for the T-cell receptor, CD28 and 4-1BB
MV Maus et al.
NATURE BIOTECHNOLOGY (2002)
Enhanced therapeutic potential of adoptive immunotherapy by in vitro CD28/4-1BB costimulation of tumor-reactive T cells against a poorly immunogenic, major histocompatibility complex class I-negative A9P melanoma
SE Strome et al.
JOURNAL OF IMMUNOTHERAPY (2000)
Rejection of disseminated metastases of colon carcinoma by synergism of IL-12 gene therapy and 4-1BB costimulation
SH Chen et al.
MOLECULAR THERAPY (2000)
Immunomodulatory gene therapy with interleukin 12 and 4-1BB ligand: Long-term remission of liver metastases in a mouse model
O Martinet et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
Share Paper
